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We report a case of granulocyte-colony stimulating factor (G-CSF) producing inﬁltrating urothelial car-
cinoma of the left renal pelvis. The patient was referred to our hospital for fever and anorexia. Blood tests
showed elevated level of leukocytosis without any infectious diseases. The serum concentration of G-CSF
was remarkably elevated. Abdominal computed tomography (CT) revealed a huge mass in the left renal
pelvis and para-aortic lymph node enlargement. He was underwent left nephroureterectomy and para-
aortic lymphadenectomy. The histological examination revealed inﬁltrating urothelial carcinoma with
positive staining for G-CSF antibody. The postoperative course was smooth and the leukocyte count
became normalized within a week postoperatively. However, multiple lung metastasis and leukocytosis
were revealed about 2 months after the operation. G-CSF producing inﬁltrating urothelial carcinoma of
the renal pelvis is reported to have a signiﬁcantly poor prognosis, so it is very important to monitor
closely after the operation.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction C-reactive protein level was 11.0 mg/dL. The serum concentration ofCarcinomas producing granulocyte-colony stimulating factor
(G-CSF) is known to occur in multiple cancers. It is reported that
about half of them are found in lung cancers. In urological ﬁeld,
we reveal most of them in urinary bladder cancers. G-CSF pro-
ducing renal pelvic carcinoma is rare, especially inﬁltrating uro-
thelial carcinoma is very rare. It is known to be extremely
malignant and a poor prognosis. Herein, we report a case of
G-CSF producing inﬁltrating urothelial carcinoma of the left renal
pelvis.Case presentation
A 67-year-old man visited our hospital due to fever and
anorexia. He was admitted to our hospital and underwent serial
examinations. Physical examination revealed a largemass in the left
abdominal region. Blood tests showed severe inﬂammation. The
leukocyte count was 22,900/mm3 with 74% segmented form. They, JCHO Saitama Medical
Saitama 330-0074, Japan.
i).
Inc. This is an open access article uG-CSF was 77.8 pg/mL (Quantikine Human G-CSF Immunoassay;
normal range < 39 pg/mL).
There was no evidence of infectious diseases. Cystoscopy
revealed no abnormal ﬁndings.
Abdominal computed tomography (CT) revealed a huge mass
measuring 12 17 cm in the left renal pelvis and para-aortic lymph
node enlargement (Fig. 1). Urinary cytology of the left renal pelvis
was positive for malignant cells.
He was underwent left nephroureterectomy and para-aortic
lymphadenectomy. The histological examination revealed inﬁl-
trating urothelial carcinoma of the left renal pelvis with squamous
differentiation and para-aortic lymph node metastasis (pT3N1M0)
(Fig. 2A). Immunohistochemical staining using anti-G-CSF antibody
demonstrated G-CSF secreting cells (Fig. 2B). After the operation,
the leukocyte count became normalized within a week. The post-
operative course was smooth and he was discharged on the 28th
postoperative day. Two months after the operation, we revealed
multiple lung metastasis and leukocytosis (Fig. 3).Discussion
Granulocyte-colony stimulating factor (G-CSF) is produced by
endothelium, macrophages, and a number of other immune cells.
G-CSF is a glycoprotein that stimulates the bonemarrow to producender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Abdominal computed tomography showed a huge mass measuring
12  17 cm in the left renal pelvis, and para-aortic lymph node enlargement. Red arrow
heads indicate the location of the tumor.
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Functionally, it is a cytokine and hormone, a type of colony-
stimulating factor, and it also stimulates the survival, prolifera-
tion, differentiation, and function of neutrophil precursors and
mature neutrophils.
In 1967, Robinson et al ﬁrst reported that elevated level of G-CSF
production with malignant tumors showed marked neutrocytosis.1
Asano et al detected that mice transplanted human lung carcinoma
tissue had remarkable degree of G-CSF and leukocytosis in serum in
1977.2Figure 2. A: Histological examination showed high grade urothelial carcinoma with squam
were positive for G-CSF, stained brown (anti G-CSF antibody staining 400).It is reported that G-CSF producing carcinomas occur in many
organs such as lung, stomach, liver, thyroid gland, urinary bladder
and so on. It is very important to consider about G-CSF producing
tumors, if we see a patient with severe degree of leukocytosis with
no obvious infections or hematologic diseases. Actually, in our case,
we ﬁrst thought leukocytosis was caused by infection. We per-
formed antibiotic treatment.
Diagnostic criterions for G-CSF producing tumors are as follows:
i) remarkable degree of leukocytosis and G-CSF in serum,
ii) decrease of elevated leukocytosis and G-CSF along with the
treatment, and iii) detection of G-CSF activation in tumors. Recently,
it is getting easier to diagnose with the advent of immunohisto-
chemical staining using anti-granulocyte-colony stimulating factor
antibody.
One of the reasons why the prognosis is signiﬁcantly poor is
considered to be due to the existence of VEGF which is a
proangiogenic factor. Overexpression of proangiogenic factors
produced by the tumors can promote neovascularity. Hyper-
vascularity in urothelial carcinomas of renal pelvis is rare
characteristic. It is reported that VEGF was also shown to promote
invasion and metastasis of urothelial tumors. According to recent
reports, VEGF protects tumor cells from chemotherapy-induced
apoptosis.3
Among G-CSF producing urothelial carcinomas of the renal
pelvis, inﬁltrating urothelial carcinomas have worse prognosis.
Because, when we reveal the tumors, about half of them
already have lymph node metastasis or invasions to the
surroundings.
Higaki et al reported that the most effective treatment for G-CSF
producing renal pelvic tumors was surgical resection.4 Others re-
ported chemotherapy was also effective, but the regimen of
chemotherapy still has not been decided. It depends on the indi-
vidual pathological ﬁndings of the tumor. Recent studies demon-
strate that G-CSF receptor autocrine activates the proliferation or
invasion in several cancers. Tachibana et al demonstrated that anti-
G-CSF antibody suppressed the proliferation of the G-CSF producing
tumors. Therefore, anti-G-CSF antibody therapy can be an effective
and alternative therapy in the case of G-CSF producing tumors.5
In conclusion, whenwe see a patient with remarkably degree of
leukocytosis, we should consider G-CSF producing carcinomas and
examine the patients carefully.
Herein, we reported a case of G-CSF producing inﬁltrating uro-
thelial carcinoma of the renal pelvis. To our knowledge, this case is
the second case of G-CSF producing inﬁltrating urothelial carci-
noma of the renal pelvis in the English literature.ous differentiation (HE 400). B: Immunohistochemical stain showed the tumor cells
Figure 3. CT showed multiple lung metastasis 2 months after the operation. Red arrow heads show the metastasis of lungs.
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